Premera Launches Fresh Takeda Antitrust Suit Over IBS Drug
A Blue Cross affiliate has once again lodged a proposed class action against Takeda Pharmaceuticals over an alleged conspiracy to keep generic versions of the drug Amitiza off the market, filing...To view the full article, register now.
Already a subscriber? Click here to view full article